Enhancement of antifungal chemotheraphy by interferon-gamma in experimental systemic cryptococcosis

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 3, 2000, Pages 437-442

  Lutz, J E ^a   Clemons, K V ^a   Stevens, D A ^a  

^a SANTA CLARA VALLEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; CHLORAMPHENICOL; FLUCONAZOLE; GAMMA INTERFERON; AMPHOTERICIN B; ANTIFUNGAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; BRAIN INFECTION; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; HEPATITIS; IMMUNOTHERAPY; MALE; MOUSE; NONHUMAN; SURVIVAL RATE; ANIMAL; BACTERIAL COUNT; BAGG ALBINO MOUSE; BLOOD; BRAIN; DISEASE MODEL; DRUG COMBINATION; HUMAN; ISOLATION AND PURIFICATION; LIVER; MICROBIOLOGY;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; BRAIN; COLONY COUNT, MICROBIAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FLUCONAZOLE; HUMANS; INTERFERON TYPE II; LIVER; MALE; MICE; MICE, INBRED BALB C;

EID: 0033624393     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cryptococcosis in the era of AIDS-100 years after the discovery of Cryptococcus neoformans
2. Cryptococcal meningitis and AIDS
3. Fungicidal activity of interferon-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans
4. Anticryptococcal activity of NK cell-enriched peripheral blood lymphocytes from human immunodeficiency virus-infected subjects: Responses to interleukin-2, interferon-gamma, and interleukin-12
5. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism
6. Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans
7. Interferon-gamma activates rat alveolar macrophages for anticryptococcal activity
8. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice
9. T cell-dependent activation of macrophages and enhancement of their phagocytic activity in the lungs of mice inoculated with heat-killed Cryptococcus neoformans: Involvement of IFN-gamma and its protective effect against cryptococcal infec
10. Contribution of interferon-gamma in protecting mice during pulmonary and disseminated infection with Cryptococcus neoformans
11. A monoclonal antibody to gamma interferon blocks augmentation of natural killer cell activity induced during systemic cryptococcosis
12. In vivo activity of interferon-gamma in combination with amphotericin B in the treatment of experimental cryptococcosis
13. Comparison of Fungizone, Amphotec, AmBisome, and Abelcet for treatment of systemic murine cryptococcosis
14. Efficacy and safety of amphotericin B colloidal dispersion compared with those of amphotericin B deoxycholate suspension for treatment of disseminated murine cryptococcosis
15. Effect of hydroxypropyl-beta-cyclodextrin on efficacy of oral itraconazole in disseminated murine cryptococcosis
16. In vitro antifungal activity of novel azole derivatives with a morpholine ring, UR-9746 and UR-9751, and comparison with fluconazole
17. Pharmacokinetics of recombinant murine interferon-gamma and human interferon-alphaA/D (Bgl). administered in concert and their influence on natural killer cell function in mice
18. Effect of cytokines on anticryptococcal activity of human microglial cells
19. Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells
20. In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B
21. Synergic inhibitory activity of amphotericin B and gamma interferon against intracellular Cryptococcus neoformans in murine macrophages
22. Cytokine treatment of central nervous system infection: Efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis
23. IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans
24. Interferon-gamma reduces the capacity of human alveolar macrophages to inhibit growth of Cryptococcus neoformans in vitro